What is the difference between cytolytic vaginosis and bacterial vaginosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differences Between Cytolytic Vaginosis and Bacterial Vaginosis

Cytolytic vaginosis and bacterial vaginosis are distinct vaginal conditions with opposite microbiological profiles, different diagnostic criteria, and contrasting treatment approaches. 1, 2

Microbiological Differences

  • Bacterial Vaginosis (BV): Characterized by replacement of normal H₂O₂-producing Lactobacillus species with high concentrations of anaerobic bacteria (Prevotella sp., Mobiluncus sp.), Gardnerella vaginalis, and Mycoplasma hominis 3

  • Cytolytic Vaginosis (CV): Characterized by an overgrowth of lactobacilli in the vaginal flora, leading to cytolysis (breakdown) of vaginal epithelial cells 1, 2

Diagnostic Criteria

Bacterial Vaginosis

BV can be diagnosed using clinical criteria (Amsel criteria) requiring three of the following:

  • Homogeneous, white, non-inflammatory discharge that smoothly coats vaginal walls 3
  • Presence of clue cells on microscopic examination 3
  • Vaginal fluid pH greater than 4.5 3
  • Fishy odor of vaginal discharge before or after addition of 10% KOH (whiff test) 3

Cytolytic Vaginosis

CV is diagnosed based on:

  • Vaginal pH ≤ 4.5 (acidic) 1, 2
  • Large number of lactobacilli on Gram staining 1, 4
  • Presence of false clue cells 1
  • Cytolysis in vaginal epithelial cells 1, 4
  • Absence or deficiency of leukocytes 1, 2
  • Absence of Trichomonas, BV, or vulvovaginal candidiasis 1, 2

Clinical Presentation

Bacterial Vaginosis

  • Most prevalent cause of vaginal discharge and malodor 3
  • Up to 50% of women with BV may be asymptomatic 3
  • Characteristic fishy odor 3
  • Not typically associated with significant vulvar irritation 3

Cytolytic Vaginosis

  • Presents with discharge, itching, dyspareunia, and dysuria 1, 5
  • Often has a cyclical pattern with symptoms worsening during luteal phase of menstrual cycle 5, 2
  • No fishy odor 2
  • Often misdiagnosed as vulvovaginal candidiasis due to similar symptoms 4, 5

Treatment Approaches

Bacterial Vaginosis

  • Treated with antibiotics such as metronidazole (500 mg orally twice daily for 7 days) or clindamycin 3, 6
  • High recurrence rate (50-80% within a year) 6
  • Treatment of male sexual partners not beneficial in preventing recurrence 3

Cytolytic Vaginosis

  • No antimicrobial treatment required 1
  • Managed with alkalinizing measures such as sodium bicarbonate (baking soda) sitz baths or douches to raise vaginal pH 4, 2
  • Discontinuation of antifungal agents that may have been inappropriately prescribed 5
  • Using pads instead of tampons during menstruation 5

Clinical Significance and Pitfalls

  • CV is frequently misdiagnosed as vulvovaginal candidiasis, leading to inappropriate and ineffective antifungal treatment 4, 5
  • Proper microscopic examination is crucial for differentiating between these conditions 1, 2
  • BV is associated with increased risk for PID, preterm birth, and increased susceptibility to STIs, while CV is not associated with these complications 3, 6
  • CV has been reported in approximately 1.7-19.4% of women with vaginitis symptoms, making it an important differential diagnosis 1, 4

Diagnostic Pearls

  • The pH test is a key differentiator: BV typically has pH > 4.5, while CV has pH ≤ 4.5 3, 1
  • Microscopic examination reveals opposite findings: BV shows few lactobacilli and many anaerobes, while CV shows abundant lactobacilli 1, 2
  • The presence of epithelial cytolysis has high specificity (99%) for CV 1
  • False clue cells in CV may be confused with true clue cells in BV, requiring careful microscopic assessment 1

References

Research

Cytolytic vaginosis.

American journal of obstetrics and gynecology, 1991

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.